Drugs Controller General of India, DGCI has given approval for restricted use in emergency situation of two Covid19 vaccines- Astra Zeneca’s Covishield and Bharat Biotech’s Covaxin.
The decision of the DGCI came after the Subject Expert Committee (SEC) of Central Drugs Standard Control Organisation (CDSCO) recommended for their emergency use.
The expert panel of the drug regulator gave its recommendation for the emergency use authorisation of Oxford AstraZeneca’s Covishield and Bharat Biotech’s Covaxin COVID-19 vaccines.
On January 1, Covishield was recommended for emergency use while COVAXIN was recommended for restricted use yesterday.
The announcement in this regard was made by DGCI V G Somani The Drug Controller General of India VG Somani said during a press conference this morning that both firms submitted data on their trial runs and both have been granted permission for restricted use.
Support Ethical Journalism. Support The Dispatch
The Dispatch is a sincere effort in ethical journalism. Truth, Accuracy, Independence, Fairness, Impartiality, Humanity and Accountability are key elements of our editorial policy. But we are still not able to generate great stories, because we don’t have adequate resources. As more and more media falls into corporate and political control, informed citizens across the world are funding independent journalism initiatives. Here is your chance to support your local media startup and help independent journalism survive. Click the link below to make a payment of your choice and be a stakeholder in public spirited journalism